These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 3901562

  • 1. [Controlled study on the treatment of hypertension with verapamil in retard form].
    Belz GG, Spies G.
    Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S, Rietbrock S, Thürmann P.
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [Abstract] [Full Text] [Related]

  • 3. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS.
    J Assoc Physicians India; 1998 Feb; Suppl 1():30-40. PubMed ID: 11233385
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER, Botero R, Octavio JA, Berrizbeitia ML, Mayorca E, Castro P, Miranda R, Valecillo E, Aroca G, Aza G, González M.
    Am J Ther; 2007 Feb; 14(2):140-6. PubMed ID: 17414581
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
    Di Somma S, Petitto M, Liguori V, Carotenuto A, Paulucci A, De Divitiis O.
    Arzneimittelforschung; 1992 Feb; 42(2):103-7. PubMed ID: 1610414
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U, Blasini R, Rudolph W.
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [Abstract] [Full Text] [Related]

  • 7. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE, Mohiuddin SM, Lucas BD, Shinn B, Elsasser GN.
    Clin Ther; 1993 Aug; 15(6):1002-10. PubMed ID: 8111798
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension].
    Pivac N, Dobovisek J, Bagatin J, Gros Furek V, Rumboldt Z, Janezić A, Kveder R, Sjerobabski V, Simunić M, Sardelić S.
    Lijec Vjesn; 1993 Aug; 115(11-12):356-9. PubMed ID: 8176999
    [Abstract] [Full Text] [Related]

  • 9. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW, Heusner JJ, DesChamps M, Gray J, Spyker DA, Peace KE, Dickson B.
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [Abstract] [Full Text] [Related]

  • 10. Favourable interaction of calcium antagonist plus ACE inhibitor on cardiac haemodynamics in treating hypertension: rest and effort evaluation.
    Di Somma S, Carotenuto A, de Divitiis M, Paulucci A, Galderisi M, Cuocolo A, de Divitiis O.
    J Hum Hypertens; 1995 Mar; 9(3):163-8. PubMed ID: 7783096
    [Abstract] [Full Text] [Related]

  • 11. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 12. [Comparative evaluation of 3 calcium antagonist drugs in patients with stable angina of effort. Double-blind placebo-controlled randomized study].
    Fazzini PF, Pucci PD, Santoro GM, Buonamici P, Buzzigoli A, Sarro F.
    G Ital Cardiol; 1987 Mar; 17(3):239-45. PubMed ID: 3301505
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Bravo EL, Krakoff LR, Tuck ML, Friedman CP.
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319
    [Abstract] [Full Text] [Related]

  • 14. [The effect of diltiazem and nifedipine in persons with essential hypertension].
    Simić D, Jurman V.
    Lijec Vjesn; 1990 Dec; 112(5-6):168-71. PubMed ID: 2233115
    [Abstract] [Full Text] [Related]

  • 15. Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension.
    Clamp M, Holmes B, Wilcox R.
    J Hum Hypertens; 1990 Oct; 4(5):557-63. PubMed ID: 2283646
    [Abstract] [Full Text] [Related]

  • 16. Verapamil compared with nifedipine in the treatment of essential hypertension.
    Midtbø K, Hals O, van der Meer J.
    J Cardiovasc Pharmacol; 1982 Oct; 4 Suppl 3():S363-8. PubMed ID: 6184569
    [Abstract] [Full Text] [Related]

  • 17. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
    Burger KJ, Anlauf M.
    Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
    [Abstract] [Full Text] [Related]

  • 18. Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40-5967), a novel calcium antagonist.
    Petrie JR, Glen SK, MacMahon M, Crome R, Meredith PA, Elliott HL, Reid JL.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1842-6. PubMed ID: 8903664
    [Abstract] [Full Text] [Related]

  • 19. [Sustained release verapamil in essential hypertension].
    Yodfat Y, Nusbaum M, Gibor Y.
    Harefuah; 1991 May 15; 120(10):581-4. PubMed ID: 1937192
    [Abstract] [Full Text] [Related]

  • 20. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG, Kramer HJ.
    J Hum Hypertens; 1994 Oct 15; 8(10):777-80. PubMed ID: 7837215
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.